A previous study carried out in patients with rare defects in the gene encoding POMC, showing obesity as well as hyperphagia, hypopigmentation, and early-onset hypocortisolism, showed that treatment with setmelanotide induced a decrease in appetite and significant weight loss [51]. The gene discussed is POMC; the disease is obesity due to melanocortin 4 receptor deficiency.